Mid-South Urgent Care, PLLC

Mid-South Urgent Care, PLLC was paid $917K by Medicaid between Jan 2018 and Dec 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	3,822	$108K
2019	3,813	$103K
2020	1,598	$62K
2021	2,611	$89K
2022	5,530	$191K
2023	7,657	$192K
2024incomplete	6,993	$172K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	27%	6,969	5,916	$250K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	25%	4,614	3,555	$226K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	15%	2,214	1,998	$134K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	10%	3,066	2,717	$92K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	6.0%	684	590	$55K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	5.4%	4,854	2,307	$49K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	3.7%	281	248	$34K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	2.9%	2,067	1,590	$27K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	2.0%	1,903	1,656	$18K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	296	263	$7K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	88	75	$7K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	145	134	$6K

12 more codes

G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	356	$4K
81003		<1%	2,303	$3K
99215	Doctor's office visit, returning patient (complex)	<1%	19	$1K
81025		<1%	265	$989.95
71046	Radiologic examination, chest; 2 views	<1%	58	$884.85
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	851	$687.72
36415	Collection of venous blood by venipuncture	<1%	388	$531.51
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	34	$333.38
90688		<1%	32	$221.72
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	74	$162.03
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	320	$136.53
H0033	Oral medication administration, direct observation	<1%	143	$83.20

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBAH, MOHAMMED (PRESIDENT)